bepridil has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 8 studies
Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 7.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 3.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "Bepridil was prescribed at a mean dose of 156+/-40 mg/day." | 2.73 | Bepridil for drug-refractory ventricular tachyarrhythmias. ( Aizawa, Y; Chinushi, M; Furushima, H; Izumi, D; Komura, S; Okamura, K; Tanabe, Y; Washizuka, T; Watanabe, H, 2007) |
| "The most important arrhythmia is ventricular tachycardia which degenerates to ventricular fibrillation." | 2.43 | [Strategy for cardiac arrhythmias in acute coronary syndrome]. ( Sugi, K, 2006) |
| "However, ventricular tachycardia (VT)/ventricular fibrillation (VF) occurred spontaneously and converted to sinus rhythm with direct current shock (300 J)." | 1.31 | [Successful hybrid therapy combined with oral bepridil and ICD in a patient with amiodarone refractory life-threatening ventricular tachyarrhythmia associated with ischemic cardiomyopathy]. ( Abe, H; Nakashima, Y; Oginosawa, Y; Okazaki, M; Suzuki, Y, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumi, D | 2 |
| Chinushi, M | 2 |
| Iijima, K | 1 |
| Ahara, S | 1 |
| Komura, S | 2 |
| Furushima, H | 2 |
| Hosaka, Y | 1 |
| Sanada, A | 1 |
| Yagihara, N | 1 |
| Aizawa, Y | 2 |
| Takanari, H | 1 |
| Honjo, H | 1 |
| Takemoto, Y | 1 |
| Suzuki, T | 1 |
| Kato, S | 1 |
| Harada, M | 1 |
| Okuno, Y | 1 |
| Ashihara, T | 1 |
| Opthof, T | 1 |
| Sakuma, I | 1 |
| Kamiya, K | 1 |
| Kodama, I | 1 |
| Oginosawa, Y | 1 |
| Abe, H | 1 |
| Suzuki, Y | 1 |
| Okazaki, M | 1 |
| Nakashima, Y | 1 |
| Sugi, K | 1 |
| Kimura, M | 1 |
| Ogawa, H | 1 |
| Wakeyama, T | 1 |
| Takaki, A | 1 |
| Iwami, T | 1 |
| Hadano, Y | 1 |
| Miyazaki, Y | 1 |
| Shimizu, A | 1 |
| Matsuzaki, M | 1 |
| Watanabe, H | 1 |
| Washizuka, T | 1 |
| Okamura, K | 1 |
| Tanabe, Y | 1 |
| Coumel, P | 1 |
| Leenhardt, A | 1 |
| Makkar, RR | 1 |
| Fromm, BS | 1 |
| Steinman, RT | 1 |
| Meissner, MD | 1 |
| Lehmann, MH | 1 |
2 reviews available for bepridil and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
[Strategy for cardiac arrhythmias in acute coronary syndrome].
Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Elect | 2006 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramid | 1993 |
1 trial available for bepridil and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Bepridil for drug-refractory ventricular tachyarrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Bepridil; Defibrillators, Implantable; Electrocardiography; Fem | 2007 |
5 other studies available for bepridil and Atrioventricular Nodal Re-Entrant Tachycardia
| Article | Year |
|---|---|
Effects of bepridil versus E-4031 on transmural ventricular repolarization and inducibility of ventricular tachyarrhythmias in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Bepridil; Blood Pressure; Calcium Channel Blockers; Cerebral Revasc | 2010 |
Bepridil facilitates early termination of spiral-wave reentry in two-dimensional cardiac muscle through an increase of intercellular electrical coupling.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Bepridil; Cells, Cultured; Electrophysiological | 2011 |
[Successful hybrid therapy combined with oral bepridil and ICD in a patient with amiodarone refractory life-threatening ventricular tachyarrhythmia associated with ischemic cardiomyopathy].
Topics: Administration, Oral; Aged; Bepridil; Defibrillators, Implantable; Humans; Male; Myocardial Ischemia | 2002 |
[Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cardiomy | 2006 |
Antiarrhythmic drugs: how to evaluate them?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Bepridil; Cardiac Complexes, Premature; Electro | 1994 |